WEDNESDAY, May 26, 2021 (HealthDay News) — A widely used medicine for autoimmune diseases may lower people’s immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis. “OurContinue Reading
FRIDAY, May 21, 2021 (HealthDay News) — A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition — eczema. In two phase 3 clinical trials, patients with moderate to severe eczema showed rapid and significant improvements after taking the drug, said researchers atContinue Reading
THURSDAY, May 20, 2021 (HealthDay News) — A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say. Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% takeContinue Reading
TUESDAY, May 18, 2021 (HealthDay News) — New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say. Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one inContinue Reading
MONDAY, May 3, 2021 (HealthDay News) — Parkinson’s disease is widely seen as a movement disorder, but it can cause an array of symptoms, including hallucinations. Now a new study has shed light on what is happening in the brain during those disturbances. The study focused on Parkinson’s patients whoContinue Reading
FRIDAY, April 30, 2021 (HealthDay News) — COVID-19 infections may last longer in young people with weakened immune systems, and that extended period could lead to more mutations in SARS-CoV-2, according to the authors of a new case study. The study included two children and a young adult who hadContinue Reading
MONDAY, April 26, 2021 (HealthDay News) — A breakthrough psoriasis drug is better at treating the itchy and painful skin disease than medicines already on the market, according to results from two clinical trials. There was a “night and day difference” in the results from bimekizumab compared against two establishedContinue Reading
WEDNESDAY, April 21, 2021 (HealthDay News) — People who suffer a traumatic brain injury (TBI) have a significantly higher risk for stroke for years afterward, U.K. researchers say. Previous studies have linked brain injury with a long-term risk of neurological diseases including dementia, Parkinson’s and epilepsy, and it’s been suggestedContinue Reading
TUESDAY, April 20, 2021 (HealthDay News) — Men with certain sleep problems, like sleep walking, may be at a higher risk of developing Parkinson’s disease, a new study suggests. Among nearly 26,000 men, researchers found those who sleepwalked or had rapid eye movement sleep behavior disorder (RBD) had a fourContinue Reading
WEDNESDAY, April 7, 2021 (HealthDay News) — Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it’s highly doubtful the vaccine is to blame, according to a just-published case study. Although both people were in the same trial, one was given the vaccine and theContinue Reading